Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 250

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2

Open access
Zhang, Mingming, Pan, Yida, Dorfman, Robert G., Yin, Yuyao, Zhou, Qian, Huang, Shan, Liu, Jie, Zhao, Shimin·2017·Scientific Reports

Abstract

Phosphoenolpyruvate carboxykinase 1 (PEPCK1) is the critical enzyme for gluconeogenesis and is linked with type II diabetes. Previous studies have found that SIRT2, a deacetylase, plays an important role in deacetylating PEPCK1 and little is known about the anti-diabetic activity of SIRT2 inhibitors. In this study, we investigated the anti-diabetic effects of sirtinol, a SIRT2 inhibitor, on cell gluconeogenesis in vivo and in vitro. Immunoblotting analysis revealed that sirtinol significantly decreased the protein level of PEPCK1, and was accompanied by the hyperacetylation of PEPCK1 as well as decreased glucose output in a dose-dependent manner. Furthermore, sirtinol exerted little impact on endogenous PEPCK1 levels in SIRT2-knockdown cells. The in vitro experiments further confirmed the in vivo data; sirtinol decreased liver PEPCK1 protein level and prevented pyruvate-induced blood glucose from increasing. Based on our results, the rate-limiting enzyme PEPCK1 is the primary target of sirtinol, and the inhibition of SIRT2 activity may play an important role in cell gluconeogenesis. Thus, SIRT2 may be a novel molecular target for diabetes therapy and may thus shed light on the underlying diabetes treatment mechanisms of sirtinol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-00035-9

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 28

  1. Wang, Q. et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327, 1004–1007, doi:10.1126/science.1179687327/5968/1004 [pii] (2010). · DOI · Paper page
  2. Granner, D. K. & O’Brien, R. M. Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care 15, 369–395 (1992). · DOI
  3. Matsuoka, H. et al. Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor alpha. PLoS One 10, e0137955, doi:10.1371/journal.pone.0137955PONE-D-15-26021 [pii] (2015). · DOI
  4. Hanson, R. W. & Patel, Y. M. Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme. Adv Enzymol Relat Areas Mol Biol 69, 203–281 (1994).
  5. Nye, C. K., Hanson, R. W. & Kalhan, S. C. Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. J Biol Chem 283, 27565–27574, doi:10.1074/jbc.M804393200M804393200 [pii] (2008). · DOI · Paper page
  6. Tannen, R. L. Ammonia metabolism. Am J Physiol 235, F265–277 (1978).
  7. Chakravarty, K., Cassuto, H., Reshef, L. & Hanson, R. W. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol 40, 129–154, doi:10.1080/10409230590935479 (2005). · DOI · Paper page
  8. Lin, Y. Y. et al. Protein Acetylation Microarray Reveals that NuA4 Controls Key Metabolic Target Regulating Gluconeogenesis. Cell 136, 1073–1084, doi:10.1016/j.cell.2009.01.033 (2009). · DOI · Paper page
  9. Blander, G. & Guarente, L. The Sir2 family of protein deacetylases. Annu Rev Biochem 73, 417–435, doi:10.1146/annurev.biochem.73.011303.073651 (2004). · DOI · Paper page
  10. Frye, R. A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260, 273–279, doi:10.1006/bbrc.1999.0897S0006-291X(99)90897-5 [pii] (1999). · DOI · Paper page
  11. Tanner, K. G., Landry, J., Sternglanz, R. & Denu, J. M. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 97, 14178–14182, doi:10.1073/pnas.250422697250422697 [pii] (2000). · DOI · Paper page
  12. North, B. J. & Verdin, E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol 5, 224, doi:10.1186/gb-2004-5-5-224gb-2004-5-5-224 [pii] (2004). · DOI
  13. North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M. & Verdin, E. The human Sir2 ortholog, SIRT2, is an NAD(+)-dependent tubulin deacetylase. Mol Cell 11, 437–444, doi:10.1016/S1097-2765(03)00038-8 (2003). · DOI · Paper page
  14. Heltweg, B. et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66, 4368–4377 (2006). doi:66/8/4368[pii]10.1158/0008-5472.CAN-05-3617 (2006) · DOI · Paper page
  15. Kozako, T. et al. High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells. Int J Cancer 131, 2044–2055, doi:10.1002/ijc.27481 (2012). · DOI
  16. Wang, J. et al. Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. Int J Oncol 41, 1101–1109, doi:10.3892/ijo.2012.1534 (2012). · DOI
  17. Hsu, Y. F. et al. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells. Biochim Biophys Acta 1820, 104–115, doi:10.1016/j.bbagen.2011.11.011S0304-4165(11)00288-1 [pii] (2012). · DOI
  18. Kanda, T. et al. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity. Biochem Biophys Res Commun 466, 567–571, doi:10.1016/j.bbrc.2015.09.083S0006-291X(15)30600-8 [pii] (2015). · doi:10.1016/j.bbrc.2015.09.083
  19. Liu, F. C., Day, Y. J., Liou, J. T., Lau, Y. T. & Yu, H. P. Sirtinol attenuates hepatic injury and pro-inflammatory cytokine production following trauma-hemorrhage in male Sprague-Dawley rats. Acta Anaesthesiol Scand 52, 635–640, doi:10.1111/j.1399-6576.2008.01592.xAAS1592 [pii] (2008). · doi:10.1111/j.1399-6576.2008.01592.x
  20. Jiang, W. Q. et al. Acetylation Regulates Gluconeogenesis by Promoting PEPCK1 Degradation via Recruiting the UBR5 Ubiquitin Ligase. Mol Cell 43, 33–44, doi:10.1016/j.molcel.2011.04.028 (2011). · DOI · Paper page
  21. North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M. & Verdin, E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11, 437–444, doi:S1097276503000388 [pii] (2003). · DOI · Paper page
  22. North, B. J. & Verdin, E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J Biol Chem 282, 19546–19555, doi:M702990200 [pii]10.1074/jbc.M702990200 (2007). · DOI · Paper page
  23. Heltweg, B. et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66, 4368–4377, doi:10.1158/0008-5472.Can-05-3617 (2006). · DOI · Paper page
  24. Liu, T., Liu, P. Y. & Marshall, G. M. The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer. Cancer Res 69, 1702–1705, doi:10.1158/0008-5472.Can-08-3365 (2009). · DOI · Paper page
  25. Avalos, J. L., Bever, K. M. & Wolberger, C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17, 855–868, doi:S1097-2765(05)01121-4 [pii]10.1016/j.molcel.2005.02.022 (2005). · DOI · Paper page
  26. Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D. & Schreiber, S. L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem 276, 38837–38843, doi:10.1074/jbc.M106779200M106779200 [pii] (2001). · DOI · Paper page
  27. Bedalov, A., Gatbonton, T., Irvine, W. P., Gottschling, D. E. & Simon, J. A. Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci USA 98, 15113–15118, doi:10.1073/pnas.26157439898/26/15113 [pii] (2001). · DOI · Paper page
  28. Berry, M. N. & Friend, D. S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43, 506–520 (1969). · DOI · Paper page

Cited by

See all 250

Metadata

Authors
Zhang, M., Pan, Y., Dorfman, R. G., Yin, Y., Zhou, Q., Huang, S., Liu, J., & Zhao, S.
Venue
Scientific Reports
Published
2017-02-28
Volume
7
Issue
1
Pages
7-7
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2582150774
Cited by
250
References
7
FWCI
16.77
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2. https://app.cochat.ai/papers/10.1038/s41598-017-00035-9
The paper
Zhang, M., Pan, Y., Dorfman, R. G., Yin, Y., Zhou, Q., Huang, S., Liu, J., & Zhao, S. (2017). Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2. Scientific Reports. https://doi.org/10.1038/s41598-017-00035-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.